104776-68-3

Upstream product

• 51088-25-6 2-chloro-6-fluoro-N-hydroxybenzene-1-carbonimidoyl chloride 
• 2028-63-9 but-3-yn-2-ol 

Downstream Products

• 104777-36-8 N-{4-[3-(2-Chloro-6-fluoro-phenyl)-isoxazol-5-yl]-thiazol-2-yl}-oxalamic acid 
• 104776-97-8 N-{4-[3-(2-Chloro-6-fluoro-phenyl)-isoxazol-5-yl]-thiazol-2-yl}-oxalamic acid benzyl ester 
• 104777-02-8 N-{4-[3-(2-Chloro-6-fluoro-phenyl)-isoxazol-5-yl]-thiazol-2-yl}-oxalamic acid 2-ethoxy-ethyl ester 
• 104776-84-3 4-[3-(2-Chloro-6-fluoro-phenyl)-isoxazol-5-yl]-thiazol-2-ylamine 
• 104776-73-0 2-Bromo-1-[3-(2-chloro-6-fluoro-phenyl)-isoxazol-5-yl]-ethanone 
• 104776-69-4 3-(2-chloro-6-fluorophenyl)-5-acetylisoxazole 

Relevant academic research and scientific papers

N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents

A series of N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives was synthesized and tested on the passive cutaneous anaphylaxis (PCA) model in rats to verify its potential antianaphylactic activity. These compounds were prepared by reaction of an appropri

4-(isoxazolyl)-thiazole-2-oxamic acids and derivatives thereof

4-(isoxazolyl)-thiazole-2-oxamic acids, esters and salts thereof; method for preparing them and intermediate compounds useful for their preparation. Said compounds possess antiallergic and antianaphylactic activity and may be used in the pharmaceutica